期刊文献+

QSAR Studies on the Calanolide Analogues as Anti-HIV-1 Agents 被引量:1

QSAR Studies on the Calanolide Analogues as Anti-HIV-1 Agents
下载PDF
导出
摘要 The Quantitative Structure-Activity Relationship (QSAR) of a series of novel calanolide analogues,which exhibit inhibitory activities of HIV-1,has been studied with a combined method of ab initio (HF),molecular mechanics (MM+) and statistics. The established QSAR model (Eq. 1) shows a reasonable regressive performance (R2 = 0.885). Both the surface area of the substituted group attached on C10,SR3,and the distance between atoms O13 and X14 (O,N,S),L,of the calanolide analogues play important roles in determining the inhibitory activity of HIV-1. The Quantitative Structure-Activity Relationship (QSAR) of a series of novel calanolide analogues,which exhibit inhibitory activities of HIV-1,has been studied with a combined method of ab initio (HF),molecular mechanics (MM+) and statistics. The established QSAR model (Eq. 1) shows a reasonable regressive performance (R2 = 0.885). Both the surface area of the substituted group attached on C10,SR3,and the distance between atoms O13 and X14 (O,N,S),L,of the calanolide analogues play important roles in determining the inhibitory activity of HIV-1.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2010年第10期1477-1482,共6页 结构化学(英文)
基金 supported by the Scientific Research Foundation of Department of Education of Yunnan Province ( No. 09Y0181)
关键词 QSAR calanolide analogues inhibitory activities of HIV-1 QSAR, calanolide analogues, inhibitory activities of HIV-1
  • 相关文献

参考文献16

  • 1Gottlieb, M. S.; Schroff, R.; Schanker, H. M.; Weisman, J. D.; Fan, P. T.; Wolf, R. A.; Saxon, A. N. Engl. J. Med. 1981, 305, 1425-1431.
  • 2Pinner, R. W.; Teutsch, S. M.; Simonsen, L.; Klug, L. A.; Graber, J. M.; Clarke, M. A.; Berkelman, R. L.J. Am. Med. Assoc.1996, 275, 189-193.
  • 3Kashraan, Y.; Gustafson, K. R.; Fuller, R. W.; Cardellina, J. H. II.; MeMahon, J. B.; Currens, M. J.; Buckheit, R W. Jr., Hughes, S. H.; Cragg, G. M.; Boyd, M. R.J. Med. Chem. 1992, 35, 2735-2743.
  • 4Hizi, A.; Tal, R.; Shaharabany, M.; Currens, M. J.; Boyd, M. R.; Hughes, S. H.; McMahon, J. B. Antimicrob. Agents Ch. 1993, 37, 1037-1042.
  • 5Zembower, D. E.; Liao, S. Y.; Flavin, M. T.; Xu, Z. Q.; Stup, T. L.; Buckheit, R. W.; Khilevich, Jr. A., Mar, A. A.; Sheinkman, A. K.J Med Chem. 1997, 40, 1005-1017.
  • 6Galinis, D. L.; Fuller, R. W.; McKee, T. C.; Cardellina II, J. H.; Gulakowski, R. J.; MeMahon, J. B.; Boyd, M. R. J. Med. Chem. 1996, 39, 4507-4510.
  • 7Ma, T.; Liu, L.; Xue, H.; Li, L.; Hart, C. Y.; Wang, L.; Chen, Z. W.; Liu, G.J. Med. Chem. 2008, 51, 1432-1446.
  • 8Anon. Classical QSAR: Review, QSAR Comb. Sci. 2004, 23,795-821.
  • 9Loew, G. H.; Villar, H. O.; Alkorta, I. Pharm Res. 1993, 10, 475-486.
  • 10Liao, S. Y.; Chen, J. C.; Qian, L.; Shen, Y.; Zheng, K. C. QSAR Comb. Sci. 2008, 27, 280-288.

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部